Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.

Rabl M, Clark C, Dayon L, Popp J, Alzheimer’s Disease Neuroimaging Initiative

DOI: 10.1136/jnnp-2024-333819
Published: 2025 Mar 24
Container: Journal of neurology, neurosurgery, and psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jnnp-2024-333819,
  title = {Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.},
  author = {Rabl M and Clark C and Dayon L and Popp J and Alzheimer’s Disease Neuroimaging Initiative},
  year = {2025},
  journal = {Journal of neurology, neurosurgery, and psychiatry},
  doi = {10.1136/jnnp-2024-333819},
  url = {https://doi.org/10.1136/jnnp-2024-333819}
}

RIS

TY  - JOUR
TI  - Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.
AU  - Rabl M
AU  - Clark C
AU  - Dayon L
AU  - Popp J
AU  - Alzheimer’s Disease Neuroimaging Initiative
PY  - 2025
JO  - Journal of neurology, neurosurgery, and psychiatry
DO  - 10.1136/jnnp-2024-333819
UR  - https://doi.org/10.1136/jnnp-2024-333819
ER  -

APA

M, R., C, C., L, D., J, P., & Initiative, A. D. N. (2025). Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2024-333819

Source records

pubmed · retrieved 2026-09-27T08:53:48.540Z